Differences in Management Between Dermatologists and Oncologists for Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.

Oliel, Sarah; Bierbrier, Rachel; D'Aguanno, Kathleen; Esfahani, Khashayar; Pehr, Kevin

Oliel, Sarah; Bierbrier, Rachel; D'Aguanno, Kathleen; Esfahani, Khashayar; Pehr, Kevin.

Afiliação

Oliel S; Faculty of Medicine, McGill University, Montréal, QC, Canada.
Bierbrier R; Division of Dermatology, McGill University, Montréal, QC, Canada.
D'Aguanno K; Division of Dermatology, Université de Sherbrooke, Sherbrooke, QC, Canada.
Esfahani K; St. Mary's Hospital, McGill University, Montréal, QC, Canada.
Pehr K; Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montréal, QC, Canada.

J Cutan Med Surg ; 28(1): 79-81, 2024.

Article em En | MEDLINE | ID: mdl-38156654

Assuntos

Erupções Acneiformes; Oncologistas; Humanos; Dermatologistas; Erupções Acneiformes/induzido quimicamente; Erupções Acneiformes/tratamento farmacológico; Receptores ErbB

Palavras-chave

acneiform eruption; cutaneous adverse event; epidermal growth factor receptor inhibitor; papulopustular eruption; tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Erupções Acneiformes / Oncologistas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google